Creating a Pathway to Identify and Treat Influenza in Pediatric Patients

Program Overview

The use of influenza testing and antivirals in children with influenza, especially for those considered to be high risk for complications, can greatly improve outcomes for patients with pediatric influenza. This 30-minute interactive panel discussion with infectious disease experts and a patient/parent will focus on symptom recognition, potential safety issues that may occur, and practical mechanisms for implementing optimal management practices in patients with pediatric influenza.

Credit Expired

Target Audience

Pediatricians, family practice, and primary care clinicians managing pediatric patients with influenza.

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Identify influenza in young children who are all at high risk for complications
  • Differentiate between antiviral therapies for influenza prevention and treatment in young children according to their efficacy and safety
  • Personalize antiviral therapy for influenza prevention and treatment in pediatric patients

Activity Faculty

Charles P. Vega, MD, FAAFP

Charles P. Vega, MD, FAAFP

Assistant Dean, Culture and Community Education
School of Medicine
University of California – Irvine
Irvine, CA

Ravi R. Jhaveri, MD, FIDSA, FPIDS, FAAP

Ravi R. Jhaveri, MD, FIDSA, FPIDS, FAAP

Division Head, Pediatric Infectious Diseases
Ann & Robert H. Lurie Children’s Hospital of Chicago
Professor, Pediatrics
Northwestern University Feinberg School of Medicine
Chicago, IL

Claudette Poole, MD, MSPH

Claudette Poole, MD, MSPH

Assistant Professor
Associate Program Director, Pediatric Infectious Diseases Fellowship Program
University of Alabama at Birmingham
Birmingham, AL

Considering Therapies for Influenza Treatment and Post-Exposure in Children


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources